Gold Spinout & Premium Buyback: $180M Deal Funds Future? | Michelle DeCecco – Lithium Chile

In this interview, Michelle DeCecco, VP & COO of Lithium Chile (TSXV: LITH), discusses their $180M USD sale of the Arizaro project in Argentina, which boasts a pre-tax $3.8 billion NPV based on a prefeasibility study.

Dececco addresses Canada’s restrictions on Chinese mining investment, even for overseas assets. She explains the company’s rebranding to “Charge Lithium” and their Kipasa project partnership with Aramet in Chile.

Despite an 80% drop in lithium prices, Dececco remains confident in quality assets. She details plans to return value to shareholders through premium share buybacks while maintaining exposure to 11 lithium properties.


Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security. The Deep Dive and its affiliates hold no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Cambria Gold To Spin Out Mt. Margaret Copper-Gold Project Into US-Focused Entity

Two Vessels Attacked Near Strait of Hormuz Within Hours as IRGC Escalates Maritime Campaign

Related News

Is Silver Still A Buy? – The Daily Dive

Closing out the week for The Daily Dive is that of Tavi Costa, Partner &...

Friday, June 24, 2022, 01:30:00 PM

The Mechanics Of Short Selling With Ihor Dusaniwsky – The Daily Dive

Sitting down with us today on the Daily Dive is that of Ihor Dusaniwsky, Managing...

Thursday, February 25, 2021, 01:30:00 PM

SPECIAL EDITION: Swarmio Media & Globe Telecom Launch The Ember Gaming Platform In The Philippines

Today in lieu of a Daily Dive episode, we are instead launching a Deep Dive...

Thursday, May 5, 2022, 01:30:00 PM

Rick Rule: The Real Enemy to the Dollar Isn’t in Riyadh

Today on the Daily Dive, we welcome back Rick Rule, president and CEO of Rule...

Monday, January 30, 2023, 01:30:00 PM

A Medical Breakthrough the Market Overlooked | David Elsley – Cardiol Therapeutics

In this interview David Elsley, CEO of Cardiol Therapeutics (NASDAQ: CRDL) (TSXV: CRDL), shares some...
Monday, August 18, 2025, 03:53:00 PM